购物车
您的购物车当前为空
A series of a hydroxy substituted derivatives 21-28 at C-17 of the Picraline-type alkaloids have been derived as having potent SGLT inhibitory activity.

A series of a hydroxy substituted derivatives 21-28 at C-17 of the Picraline-type alkaloids have been derived as having potent SGLT inhibitory activity.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 3,940 | 待询 |
| 产品描述 | A series of a hydroxy substituted derivatives 21-28 at C-17 of the Picraline-type alkaloids have been derived as having potent SGLT inhibitory activity. |
| 靶点活性 | κ Opioid Receptor/KOR:2.38 μM (Ki), μ opioid receptor:132 μM (Ki), δ Opioid Receptor/DOR:98.8 μM (Ki) |
| 分子量 | 410.47 |
| 分子式 | C23H26N2O5 |
| CAS No. | 2671-32-1 |
| Smiles | COC(=O)[C@]1(COC(C)=O)[C@H]2C[C@@H]3N(C\C2=C\C)[C@@H]2C[C@@]11c4ccccc4N[C@@]31O2 |
| 密度 | 1.38 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多